2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …

FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

[HTML][HTML] The prevalence of polycystic ovary syndrome: a brief systematic review

R Deswal, V Narwal, A Dang… - Journal of human …, 2020 - journals.lww.com
Background: Polycystic ovary syndrome (PCOS), the major endocrinopathy among
reproductive-aged women, is not yet perceived as an important health problem in the world …

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …

AHEM Maas, G Rosano, R Cifkova… - European Heart …, 2021 - academic.oup.com
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

[HTML][HTML] Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies

MA Sanchez-Garrido, M Tena-Sempere - Molecular metabolism, 2020 - Elsevier
Background Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among
reproductive age women. Although its cardinal manifestations include hyperandrogenism …

[HTML][HTML] Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity

WM Wolf, RA Wattick, ON Kinkade… - International journal of …, 2018 - mdpi.com
Polycystic ovarian syndrome (PCOS) is thought to be the most common endocrine disorder
found in women. Common symptoms include irregular menstrual cycle, polycystic ovaries …

Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics

CJ Glueck, N Goldenberg - Metabolism, 2019 - Elsevier
Polycystic ovary syndrome (PCOS) has multiple etiologies including ovarian and adrenal
hyperandrogenism, neuro-endocrine and hypothalamic-pituitary dysfunction, and disorders …

Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017

J Liu, Q Wu, Y Hao, M Jiao, X Wang… - Human …, 2021 - academic.oup.com
STUDY QUESTION What is the current burden of polycystic ovary syndrome (PCOS) at the
global, regional, and country-specific levels in 194 countries and territories according to age …

Use of gonadotropin-releasing hormone analogs in children: update by an international consortium

K Bangalore Krishna, JS Fuqua, AD Rogol… - Hormone research in …, 2019 - karger.com
This update, written by authors designated by multiple pediatric endocrinology societies
(see List of Participating Societies) from around the globe, concisely addresses topics …

[HTML][HTML] Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

I Kyrou, E Karteris, T Robbins, K Chatha, F Drenos… - BMC medicine, 2020 - Springer
Background In women of reproductive age, polycystic ovary syndrome (PCOS) constitutes
the most frequent endocrine disorder. Women with PCOS are considered to typically belong …

[HTML][HTML] Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment

J Parker, C O'brien, J Hawrelak, FL Gersh - International journal of …, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is increasingly recognized as a complex metabolic
disorder that manifests in genetically susceptible women following a range of negative …